<table id="id_01e5e731-c238-4a1d-9a93-38051840da07" width="731.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_c156a064-03e8-4230-ac11-ea39bc76d828">Table 9 Bioavailability of Divalproex Sodium Extended-Release Tablets Relative to Divalproex Sodium Delayed-Release Tablets When Divalproex Sodium Extended-Release Tablets Dose is 8% to 20% Higher</caption>
<col width="20.2%"></col>
<col width="21.1%"></col>
<col width="19.6%"></col>
<col width="19.6%"></col>
<col width="19.6%"></col>
<tbody>
<tr id="id_6f9cede1-5a8c-4656-9250-9b5818429e6c">
<td align="center" stylecode="Toprule" valign="top">
<content stylecode="bold">Study Population</content>
</td>
<td align="center" stylecode="Toprule" valign="top">
<content stylecode="bold">Regimens</content>
</td>
<td align="center" colspan="3" valign="top">
<content stylecode="bold">Relative Bioavailability</content>
</td>
</tr>
<tr id="id_0b399cd1-b7f4-4b62-8d4a-168b1fb07508">
<td align="center" stylecode="Botrule" valign="top"></td>
<td align="center" stylecode="Botrule" valign="bottom">
<paragraph>Divalproex Sodium Extended-Release TabletsÂ  vs.<br/>
</paragraph>Divalproex Sodium Delayed-Release Tablets</td>
<td align="center" stylecode="Botrule" valign="bottom">AUC<sub>24</sub>
</td>
<td align="center" stylecode="Botrule" valign="bottom">C<sub>max</sub>
</td>
<td align="center" stylecode="Botrule" valign="bottom">C<sub>min</sub>
</td>
</tr>
<tr id="id_49870477-5413-4068-bfe6-f7b450e7d329">
<td align="center" valign="top">Healthy Volunteers<br/>(n = 35)</td>
<td align="center" valign="top">
<paragraph>1000 mg &amp; 1500 mg<br/>Divalproex Sodium Extended-Release Tablets vs.<br/>875 mg &amp; 1250 mg<br/>
</paragraph>Divalproex Sodium Delayed-Release Tablets</td>
<td align="center" valign="top">1.059</td>
<td align="center" valign="top">0.882</td>
<td align="center" valign="top">1.173</td>
</tr>
<tr id="id_ff18b292-b6a1-4880-aa94-87d851448822">
<td align="center" stylecode="Botrule" valign="top">Patients with epilepsy on concomitant enzyme-inducing antiepilepsy drugs<br/>(n = 64)</td>
<td align="center" stylecode="Botrule" valign="top">
<paragraph>1000 mg to 5000 mg<br/>Divalproex Sodium Extended-Release Tablets vs.<br/>875 mg to 4250 mg<br/>
</paragraph>Divalproex Sodium Delayed-Release Tablets</td>
<td align="center" stylecode="Botrule" valign="top">1.008</td>
<td align="center" stylecode="Botrule" valign="top">0.899</td>
<td align="center" stylecode="Botrule" valign="top">1.022</td>
</tr>
</tbody>
</table>